Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients

NCT06429761 · clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca